Commit To Buy Cytokinetics At $7, Earn 12.4% Annualized Using Options

Investors eyeing a purchase of Cytokinetics Inc (CYTK) shares, but cautious about paying the going market price of $9.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $7 strike, which has a bid at the time of this writing of 55 cents..